5 assets in Adrenal Gland Cancer

Therapeutic assets addressing Adrenal Gland Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Adrenal Gland Cancer	National Cancer Institute (NCI)	P2	CCC (53)
Floxuridine Adrenal Gland Cancer	National Cancer Institute (NCI)	P2	CCC (53)
pds01adc Adrenal Gland Cancer	National Cancer Institute (NCI)	P2	CCC (53)
Fapi-46 Adrenal Gland Cancer	Jonsson Comprehensive Cancer Center	P1	CC (43)
Fludeoxyglucose Adrenal Gland Cancer	Jonsson Comprehensive Cancer Center	P1	CC (43)